nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—Celecoxib—CA9—cervical cancer	0.051	1	CrCbGaD
Etoricoxib—MAPK14—epithelium—cervical cancer	0.0236	0.0858	CbGeAlD
Etoricoxib—MAPK14—uterine cervix—cervical cancer	0.0234	0.0851	CbGeAlD
Etoricoxib—MAPK14—decidua—cervical cancer	0.0223	0.0811	CbGeAlD
Etoricoxib—MAPK14—renal system—cervical cancer	0.0219	0.0796	CbGeAlD
Etoricoxib—MAPK14—uterus—cervical cancer	0.0195	0.0709	CbGeAlD
Etoricoxib—MAPK14—female reproductive system—cervical cancer	0.0176	0.0638	CbGeAlD
Etoricoxib—Heartburn—Topotecan—cervical cancer	0.0164	0.0555	CcSEcCtD
Etoricoxib—MAPK14—female gonad—cervical cancer	0.016	0.058	CbGeAlD
Etoricoxib—MAPK14—vagina—cervical cancer	0.0159	0.0577	CbGeAlD
Etoricoxib—MAPK14—IL6-mediated signaling events—PIAS3—cervical cancer	0.0155	0.041	CbGpPWpGaD
Etoricoxib—MAPK14—Interferon type I signaling pathways—PIAS3—cervical cancer	0.0139	0.0367	CbGpPWpGaD
Etoricoxib—MAPK14—Oncostatin M Signaling Pathway—PIAS3—cervical cancer	0.012	0.0316	CbGpPWpGaD
Etoricoxib—MAPK14—Retinoic acid receptors-mediated signaling—RARB—cervical cancer	0.0117	0.0309	CbGpPWpGaD
Etoricoxib—MAPK14—p53 pathway—YY1—cervical cancer	0.0108	0.0287	CbGpPWpGaD
Etoricoxib—Neuropathy—Topotecan—cervical cancer	0.0106	0.0359	CcSEcCtD
Etoricoxib—MAPK14—lymph node—cervical cancer	0.0103	0.0373	CbGeAlD
Etoricoxib—Neoplasm—Topotecan—cervical cancer	0.0102	0.0346	CcSEcCtD
Etoricoxib—CYP2E1—Folate-Alcohol and Cancer Pathway—MTHFR—cervical cancer	0.00876	0.0232	CbGpPWpGaD
Etoricoxib—Anaphylactoid reaction—Topotecan—cervical cancer	0.00849	0.0287	CcSEcCtD
Etoricoxib—Cardiac arrest—Topotecan—cervical cancer	0.00781	0.0264	CcSEcCtD
Etoricoxib—CYP1A2—renal system—cervical cancer	0.00761	0.0276	CbGeAlD
Etoricoxib—Aspartate aminotransferase increased—Topotecan—cervical cancer	0.0074	0.025	CcSEcCtD
Etoricoxib—Cramp muscle—Topotecan—cervical cancer	0.0074	0.025	CcSEcCtD
Etoricoxib—Alanine aminotransferase increased—Topotecan—cervical cancer	0.00725	0.0245	CcSEcCtD
Etoricoxib—CYP2E1—renal system—cervical cancer	0.00685	0.0249	CbGeAlD
Etoricoxib—PTGS2—epithelium—cervical cancer	0.0068	0.0247	CbGeAlD
Etoricoxib—CYP2C19—vagina—cervical cancer	0.00675	0.0245	CbGeAlD
Etoricoxib—PTGS2—uterine cervix—cervical cancer	0.00674	0.0245	CbGeAlD
Etoricoxib—Weight increased—Topotecan—cervical cancer	0.00646	0.0218	CcSEcCtD
Etoricoxib—Pneumonia—Topotecan—cervical cancer	0.00637	0.0215	CcSEcCtD
Etoricoxib—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.00634	0.0168	CbGpPWpGaD
Etoricoxib—Infestation—Topotecan—cervical cancer	0.00633	0.0214	CcSEcCtD
Etoricoxib—Infestation NOS—Topotecan—cervical cancer	0.00633	0.0214	CcSEcCtD
Etoricoxib—PTGS2—renal system—cervical cancer	0.0063	0.0229	CbGeAlD
Etoricoxib—PTGS2—C-MYB transcription factor network—PIAS3—cervical cancer	0.00622	0.0165	CbGpPWpGaD
Etoricoxib—Neuropathy peripheral—Topotecan—cervical cancer	0.00621	0.021	CcSEcCtD
Etoricoxib—Stomatitis—Topotecan—cervical cancer	0.00617	0.0208	CcSEcCtD
Etoricoxib—CYP2E1—Tryptophan metabolism—UBE3A—cervical cancer	0.00611	0.0162	CbGpPWpGaD
Etoricoxib—PTGS2—endometrium—cervical cancer	0.00609	0.0221	CbGeAlD
Etoricoxib—Hepatobiliary disease—Topotecan—cervical cancer	0.00599	0.0202	CcSEcCtD
Etoricoxib—Epistaxis—Topotecan—cervical cancer	0.00597	0.0202	CcSEcCtD
Etoricoxib—CYP2C9—female reproductive system—cervical cancer	0.00579	0.021	CbGeAlD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—PIAS3—cervical cancer	0.00576	0.0152	CbGpPWpGaD
Etoricoxib—Haemoglobin—Topotecan—cervical cancer	0.00571	0.0193	CcSEcCtD
Etoricoxib—Haemorrhage—Topotecan—cervical cancer	0.00568	0.0192	CcSEcCtD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—GP6—cervical cancer	0.00568	0.015	CbGpPWpGaD
Etoricoxib—Hypoaesthesia—Topotecan—cervical cancer	0.00565	0.0191	CcSEcCtD
Etoricoxib—Pharyngitis—Topotecan—cervical cancer	0.00564	0.0191	CcSEcCtD
Etoricoxib—PTGS2—uterus—cervical cancer	0.00562	0.0204	CbGeAlD
Etoricoxib—CYP3A4—renal system—cervical cancer	0.00551	0.02	CbGeAlD
Etoricoxib—CYP2E1—female reproductive system—cervical cancer	0.00548	0.0199	CbGeAlD
Etoricoxib—CYP2D6—renal system—cervical cancer	0.00542	0.0197	CbGeAlD
Etoricoxib—CYP2E1—Vitamin A and Carotenoid Metabolism—RARB—cervical cancer	0.00525	0.0139	CbGpPWpGaD
Etoricoxib—Angiopathy—Topotecan—cervical cancer	0.00516	0.0174	CcSEcCtD
Etoricoxib—Immune system disorder—Topotecan—cervical cancer	0.00513	0.0173	CcSEcCtD
Etoricoxib—Mediastinal disorder—Topotecan—cervical cancer	0.00512	0.0173	CcSEcCtD
Etoricoxib—PTGS2—female reproductive system—cervical cancer	0.00505	0.0183	CbGeAlD
Etoricoxib—Alopecia—Topotecan—cervical cancer	0.00502	0.017	CcSEcCtD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—GP5—cervical cancer	0.00496	0.0131	CbGpPWpGaD
Etoricoxib—Malnutrition—Topotecan—cervical cancer	0.00495	0.0167	CcSEcCtD
Etoricoxib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—WNT5A—cervical cancer	0.00483	0.0128	CbGpPWpGaD
Etoricoxib—Muscle spasms—Topotecan—cervical cancer	0.00476	0.0161	CcSEcCtD
Etoricoxib—PTGS2—female gonad—cervical cancer	0.00459	0.0167	CbGeAlD
Etoricoxib—Anaemia—Topotecan—cervical cancer	0.00457	0.0154	CcSEcCtD
Etoricoxib—PTGS2—vagina—cervical cancer	0.00457	0.0166	CbGeAlD
Etoricoxib—Angioedema—Topotecan—cervical cancer	0.00452	0.0153	CcSEcCtD
Etoricoxib—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.00446	0.0118	CbGpPWpGaD
Etoricoxib—CYP3A4—female reproductive system—cervical cancer	0.00441	0.016	CbGeAlD
Etoricoxib—CYP2D6—female reproductive system—cervical cancer	0.00434	0.0158	CbGeAlD
Etoricoxib—Cough—Topotecan—cervical cancer	0.00432	0.0146	CcSEcCtD
Etoricoxib—MAPK14—NOD1/2 Signaling Pathway—CASP8—cervical cancer	0.00424	0.0112	CbGpPWpGaD
Etoricoxib—Arthralgia—Topotecan—cervical cancer	0.00421	0.0142	CcSEcCtD
Etoricoxib—Chest pain—Topotecan—cervical cancer	0.00421	0.0142	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00418	0.0141	CcSEcCtD
Etoricoxib—Anaphylactic shock—Topotecan—cervical cancer	0.00404	0.0136	CcSEcCtD
Etoricoxib—Infection—Topotecan—cervical cancer	0.00401	0.0135	CcSEcCtD
Etoricoxib—Nervous system disorder—Topotecan—cervical cancer	0.00396	0.0134	CcSEcCtD
Etoricoxib—Thrombocytopenia—Topotecan—cervical cancer	0.00395	0.0134	CcSEcCtD
Etoricoxib—CYP2D6—female gonad—cervical cancer	0.00395	0.0143	CbGeAlD
Etoricoxib—Skin disorder—Topotecan—cervical cancer	0.00392	0.0132	CcSEcCtD
Etoricoxib—MAPK14—FSH signaling pathway—MTOR—cervical cancer	0.0039	0.0103	CbGpPWpGaD
Etoricoxib—Anorexia—Topotecan—cervical cancer	0.00385	0.013	CcSEcCtD
Etoricoxib—MAPK14—FAS (CD95) signaling pathway—CASP8—cervical cancer	0.00385	0.0102	CbGpPWpGaD
Etoricoxib—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.00381	0.0101	CbGpPWpGaD
Etoricoxib—MAPK14—ATF-2 transcription factor network—HES1—cervical cancer	0.00368	0.00976	CbGpPWpGaD
Etoricoxib—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00368	0.0124	CcSEcCtD
Etoricoxib—CYP1A2—Tryptophan metabolism—UBE3A—cervical cancer	0.00367	0.00972	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—INSM1—cervical cancer	0.00366	0.00969	CbGpPWpGaD
Etoricoxib—Dyspnoea—Topotecan—cervical cancer	0.0036	0.0122	CcSEcCtD
Etoricoxib—MAPK14—IL12-mediated signaling events—CD8A—cervical cancer	0.00357	0.00946	CbGpPWpGaD
Etoricoxib—Dyspepsia—Topotecan—cervical cancer	0.00355	0.012	CcSEcCtD
Etoricoxib—Decreased appetite—Topotecan—cervical cancer	0.00351	0.0119	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Topotecan—cervical cancer	0.00349	0.0118	CcSEcCtD
Etoricoxib—Fatigue—Topotecan—cervical cancer	0.00348	0.0118	CcSEcCtD
Etoricoxib—Constipation—Topotecan—cervical cancer	0.00345	0.0117	CcSEcCtD
Etoricoxib—Pain—Topotecan—cervical cancer	0.00345	0.0117	CcSEcCtD
Etoricoxib—Feeling abnormal—Topotecan—cervical cancer	0.00333	0.0112	CcSEcCtD
Etoricoxib—MAPK14—TWEAK Signaling Pathway—CASP8—cervical cancer	0.00332	0.0088	CbGpPWpGaD
Etoricoxib—MAPK14—Alpha 6 Beta 4 signaling pathway—MTOR—cervical cancer	0.00332	0.00879	CbGpPWpGaD
Etoricoxib—Gastrointestinal pain—Topotecan—cervical cancer	0.0033	0.0112	CcSEcCtD
Etoricoxib—MAPK14—CDO in myogenesis—CTNNB1—cervical cancer	0.00326	0.00864	CbGpPWpGaD
Etoricoxib—Urticaria—Topotecan—cervical cancer	0.00321	0.0108	CcSEcCtD
Etoricoxib—MAPK14—Physiological and Pathological Hypertrophy  of the Heart—STAT3—cervical cancer	0.0032	0.00848	CbGpPWpGaD
Etoricoxib—Abdominal pain—Topotecan—cervical cancer	0.00319	0.0108	CcSEcCtD
Etoricoxib—MAPK14—FGF signaling pathway—FGFR3—cervical cancer	0.00318	0.00842	CbGpPWpGaD
Etoricoxib—MAPK14—Cardiac Progenitor Differentiation—NOTCH1—cervical cancer	0.00303	0.00803	CbGpPWpGaD
Etoricoxib—Hypersensitivity—Topotecan—cervical cancer	0.00297	0.01	CcSEcCtD
Etoricoxib—MAPK14—CXCR3-mediated signaling events—MTOR—cervical cancer	0.00296	0.00785	CbGpPWpGaD
Etoricoxib—PTGS2—lymph node—cervical cancer	0.00295	0.0107	CbGeAlD
Etoricoxib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.00294	0.00779	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—SERPIND1—cervical cancer	0.00293	0.00775	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—GP6—cervical cancer	0.00293	0.00775	CbGpPWpGaD
Etoricoxib—MAPK14—FAS (CD95) signaling pathway—CASP3—cervical cancer	0.00291	0.00771	CbGpPWpGaD
Etoricoxib—Asthenia—Topotecan—cervical cancer	0.0029	0.00979	CcSEcCtD
Etoricoxib—MAPK14—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CASP8—cervical cancer	0.00289	0.00766	CbGpPWpGaD
Etoricoxib—Pruritus—Topotecan—cervical cancer	0.00286	0.00965	CcSEcCtD
Etoricoxib—CYP3A4—Tryptophan metabolism—UBE3A—cervical cancer	0.00283	0.0075	CbGpPWpGaD
Etoricoxib—Diarrhoea—Topotecan—cervical cancer	0.00276	0.00933	CcSEcCtD
Etoricoxib—MAPK14—Parkinsons Disease Pathway—CASP3—cervical cancer	0.00273	0.00722	CbGpPWpGaD
Etoricoxib—MAPK14—Amyotrophic lateral sclerosis (ALS)—CASP3—cervical cancer	0.00273	0.00722	CbGpPWpGaD
Etoricoxib—Dizziness—Topotecan—cervical cancer	0.00267	0.00902	CcSEcCtD
Etoricoxib—MAPK14—Nanoparticle-mediated activation of receptor signaling—EGFR—cervical cancer	0.00266	0.00704	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.00265	0.00702	CbGpPWpGaD
Etoricoxib—MAPK14—TCR Signaling Pathway—CD8A—cervical cancer	0.00258	0.00684	CbGpPWpGaD
Etoricoxib—Vomiting—Topotecan—cervical cancer	0.00257	0.00867	CcSEcCtD
Etoricoxib—MAPK14—Hemostasis—GP5—cervical cancer	0.00256	0.00678	CbGpPWpGaD
Etoricoxib—Rash—Topotecan—cervical cancer	0.00255	0.0086	CcSEcCtD
Etoricoxib—Dermatitis—Topotecan—cervical cancer	0.00254	0.00859	CcSEcCtD
Etoricoxib—Headache—Topotecan—cervical cancer	0.00253	0.00854	CcSEcCtD
Etoricoxib—MAPK14—TWEAK Signaling Pathway—CASP3—cervical cancer	0.00252	0.00666	CbGpPWpGaD
Etoricoxib—MAPK14—TSLP Signaling Pathway—MTOR—cervical cancer	0.0025	0.00662	CbGpPWpGaD
Etoricoxib—MAPK14—TWEAK Signaling Pathway—CTNNB1—cervical cancer	0.00243	0.00642	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—CA9—cervical cancer	0.00241	0.00637	CbGpPWpGaD
Etoricoxib—Nausea—Topotecan—cervical cancer	0.0024	0.0081	CcSEcCtD
Etoricoxib—MAPK14—AGE/RAGE pathway—CASP8—cervical cancer	0.00232	0.00613	CbGpPWpGaD
Etoricoxib—MAPK14—Interferon type I signaling pathways—MTOR—cervical cancer	0.00224	0.00592	CbGpPWpGaD
Etoricoxib—MAPK14—RANKL/RANK Signaling Pathway—MTOR—cervical cancer	0.0022	0.00584	CbGpPWpGaD
Etoricoxib—MAPK14—Cardiac Hypertrophic Response—MTOR—cervical cancer	0.0022	0.00584	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—AKAP13—cervical cancer	0.0021	0.00556	CbGpPWpGaD
Etoricoxib—MAPK14—Role of Calcineurin-dependent NFAT signaling in lymphocytes—CASP3—cervical cancer	0.00206	0.00545	CbGpPWpGaD
Etoricoxib—MAPK14—IL12-mediated signaling events—MTOR—cervical cancer	0.00206	0.00545	CbGpPWpGaD
Etoricoxib—MAPK14—IL12-mediated signaling events—CD4—cervical cancer	0.00205	0.00544	CbGpPWpGaD
Etoricoxib—MAPK14—IL4-mediated signaling events—MTOR—cervical cancer	0.002	0.0053	CbGpPWpGaD
Etoricoxib—MAPK14—RAC1 signaling pathway—CTNNB1—cervical cancer	0.00198	0.00525	CbGpPWpGaD
Etoricoxib—CYP1A2—Estrogen Receptor Pathway—STAT3—cervical cancer	0.00195	0.00517	CbGpPWpGaD
Etoricoxib—MAPK14—TSLP Signaling Pathway—STAT3—cervical cancer	0.00193	0.00512	CbGpPWpGaD
Etoricoxib—MAPK14—IL6-mediated signaling events—STAT3—cervical cancer	0.00193	0.00512	CbGpPWpGaD
Etoricoxib—MAPK14—Oncostatin M Signaling Pathway—MTOR—cervical cancer	0.00193	0.00511	CbGpPWpGaD
Etoricoxib—MAPK14—TSH signaling pathway—MTOR—cervical cancer	0.00191	0.00505	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling mediated by p38-alpha and p38-beta—TP53—cervical cancer	0.00187	0.00494	CbGpPWpGaD
Etoricoxib—MAPK14—CDC42 signaling events—MTOR—cervical cancer	0.00182	0.00481	CbGpPWpGaD
Etoricoxib—PTGS2—C-MYB transcription factor network—HES1—cervical cancer	0.00177	0.0047	CbGpPWpGaD
Etoricoxib—MAPK14—Oncostatin M Signaling Pathway—CASP3—cervical cancer	0.00177	0.0047	CbGpPWpGaD
Etoricoxib—MAPK14—AGE/RAGE pathway—CASP3—cervical cancer	0.00175	0.00464	CbGpPWpGaD
Etoricoxib—MAPK14—Amyotrophic lateral sclerosis (ALS)—TP53—cervical cancer	0.00175	0.00463	CbGpPWpGaD
Etoricoxib—MAPK14—Interferon type I signaling pathways—STAT3—cervical cancer	0.00173	0.00458	CbGpPWpGaD
Etoricoxib—MAPK14—IL-4 Signaling Pathway—STAT3—cervical cancer	0.00173	0.00458	CbGpPWpGaD
Etoricoxib—MAPK14—RAC1 signaling pathway—STAT3—cervical cancer	0.00173	0.00458	CbGpPWpGaD
Etoricoxib—MAPK14—FGF signaling pathway—STAT3—cervical cancer	0.00173	0.00458	CbGpPWpGaD
Etoricoxib—MAPK14—IL2-mediated signaling events—STAT3—cervical cancer	0.00173	0.00458	CbGpPWpGaD
Etoricoxib—MAPK14—Leptin signaling pathway—MTOR—cervical cancer	0.00172	0.00456	CbGpPWpGaD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—TERT—cervical cancer	0.0017	0.00449	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.00169	0.00448	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88-independent cascade—CASP8—cervical cancer	0.00167	0.00443	CbGpPWpGaD
Etoricoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—CTNNB1—cervical cancer	0.00167	0.00442	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling events mediated by VEGFR1 and VEGFR2—CTNNB1—cervical cancer	0.00165	0.00437	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—CASP8—cervical cancer	0.00163	0.00433	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.00163	0.0043	CbGpPWpGaD
Etoricoxib—MAPK14—CDC42 signaling events—CTNNB1—cervical cancer	0.00161	0.00427	CbGpPWpGaD
Etoricoxib—MAPK14—Kit receptor signaling pathway—STAT3—cervical cancer	0.00161	0.00427	CbGpPWpGaD
Etoricoxib—MAPK14—IL12-mediated signaling events—STAT3—cervical cancer	0.00159	0.00421	CbGpPWpGaD
Etoricoxib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—MTOR—cervical cancer	0.00157	0.00416	CbGpPWpGaD
Etoricoxib—MAPK14—Thromboxane A2 receptor signaling—EGFR—cervical cancer	0.00153	0.00404	CbGpPWpGaD
Etoricoxib—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—cervical cancer	0.00152	0.00401	CbGpPWpGaD
Etoricoxib—MAPK14—Activated TLR4 signalling—CASP8—cervical cancer	0.00151	0.00399	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—MTHFR—cervical cancer	0.0015	0.00398	CbGpPWpGaD
Etoricoxib—MAPK14—Oncostatin M Signaling Pathway—STAT3—cervical cancer	0.00149	0.00395	CbGpPWpGaD
Etoricoxib—MAPK14—TCR Signaling Pathway—CD4—cervical cancer	0.00148	0.00393	CbGpPWpGaD
Etoricoxib—MAPK14—AGE/RAGE pathway—STAT3—cervical cancer	0.00147	0.0039	CbGpPWpGaD
Etoricoxib—MAPK14—TSH signaling pathway—STAT3—cervical cancer	0.00147	0.0039	CbGpPWpGaD
Etoricoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—STAT3—cervical cancer	0.00145	0.00385	CbGpPWpGaD
Etoricoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—CASP8—cervical cancer	0.00142	0.00375	CbGpPWpGaD
Etoricoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—cervical cancer	0.0014	0.0037	CbGpPWpGaD
Etoricoxib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—CTNNB1—cervical cancer	0.00139	0.00369	CbGpPWpGaD
Etoricoxib—MAPK14—Corticotropin-releasing hormone—CASP3—cervical cancer	0.00134	0.00356	CbGpPWpGaD
Etoricoxib—MAPK14—AGE/RAGE pathway—EGFR—cervical cancer	0.00134	0.00354	CbGpPWpGaD
Etoricoxib—MAPK14—Leptin signaling pathway—STAT3—cervical cancer	0.00133	0.00352	CbGpPWpGaD
Etoricoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—EGFR—cervical cancer	0.00132	0.0035	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—MTOR—cervical cancer	0.00131	0.00348	CbGpPWpGaD
Etoricoxib—MAPK14—Corticotropin-releasing hormone—CTNNB1—cervical cancer	0.0013	0.00343	CbGpPWpGaD
Etoricoxib—MAPK14—VEGFA-VEGFR2 Pathway—MTOR—cervical cancer	0.00129	0.00343	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—CASP8—cervical cancer	0.00128	0.00338	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-Like Receptors Cascades—CASP8—cervical cancer	0.00126	0.00334	CbGpPWpGaD
Etoricoxib—MAPK14—p53 pathway—TP53—cervical cancer	0.00123	0.00325	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by VEGF—MTOR—cervical cancer	0.00122	0.00324	CbGpPWpGaD
Etoricoxib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—STAT3—cervical cancer	0.00121	0.00322	CbGpPWpGaD
Etoricoxib—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—cervical cancer	0.00119	0.00316	CbGpPWpGaD
Etoricoxib—MAPK14—VEGFA-VEGFR2 Pathway—CTNNB1—cervical cancer	0.00115	0.00304	CbGpPWpGaD
Etoricoxib—PTGS2—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.00114	0.00302	CbGpPWpGaD
Etoricoxib—MAPK14—Oncostatin M Signaling Pathway—TP53—cervical cancer	0.00114	0.00301	CbGpPWpGaD
Etoricoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—TP53—cervical cancer	0.00111	0.00294	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—CASP8—cervical cancer	0.0011	0.0029	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—FGFR3—cervical cancer	0.00109	0.00289	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by VEGF—CTNNB1—cervical cancer	0.00108	0.00287	CbGpPWpGaD
Etoricoxib—MAPK14—BDNF signaling pathway—MTOR—cervical cancer	0.00102	0.0027	CbGpPWpGaD
Etoricoxib—PTGS2—C-MYB transcription factor network—CD4—cervical cancer	0.001	0.00265	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.00099	0.00262	CbGpPWpGaD
Etoricoxib—MAPK14—Cell-Cell communication—CTNNB1—cervical cancer	0.000982	0.0026	CbGpPWpGaD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—TP53—cervical cancer	0.000945	0.0025	CbGpPWpGaD
Etoricoxib—MAPK14—BDNF signaling pathway—CASP3—cervical cancer	0.000939	0.00249	CbGpPWpGaD
Etoricoxib—MAPK14—Insulin Signaling—MTOR—cervical cancer	0.000938	0.00248	CbGpPWpGaD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—MTOR—cervical cancer	0.000929	0.00246	CbGpPWpGaD
Etoricoxib—MAPK14—BDNF signaling pathway—CTNNB1—cervical cancer	0.000905	0.0024	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—FGFR3—cervical cancer	0.000838	0.00222	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—CASP3—cervical cancer	0.00083	0.0022	CbGpPWpGaD
Etoricoxib—MAPK14—BDNF signaling pathway—STAT3—cervical cancer	0.000789	0.00209	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—UBE3A—cervical cancer	0.000782	0.00207	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—TP53—cervical cancer	0.000775	0.00205	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—MTOR—cervical cancer	0.000767	0.00203	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000749	0.00198	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000722	0.00191	CbGpPWpGaD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—STAT3—cervical cancer	0.000718	0.0019	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—CASP3—cervical cancer	0.000703	0.00186	CbGpPWpGaD
Etoricoxib—MAPK14—Oxidative Stress Induced Senescence—TP53—cervical cancer	0.000701	0.00186	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—HES1—cervical cancer	0.000673	0.00178	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TAAR6—cervical cancer	0.000657	0.00174	CbGpPWpGaD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—EGFR—cervical cancer	0.000653	0.00173	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	0.000646	0.00171	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.000646	0.00171	CbGpPWpGaD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—TP53—cervical cancer	0.000645	0.00171	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—STAT3—cervical cancer	0.000643	0.0017	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—RARB—cervical cancer	0.000634	0.00168	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—EGFR—cervical cancer	0.000634	0.00168	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000632	0.00167	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—MTOR—cervical cancer	0.000629	0.00166	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—STAT3—cervical cancer	0.000592	0.00157	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—MTOR—cervical cancer	0.00059	0.00156	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000572	0.00151	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—CASP3—cervical cancer	0.000542	0.00144	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—EGFR—cervical cancer	0.000538	0.00143	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—EGFR—cervical cancer	0.000537	0.00142	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TP53—cervical cancer	0.000532	0.00141	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—WNT2—cervical cancer	0.000513	0.00136	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—NOTCH1—cervical cancer	0.000508	0.00135	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—TP53—cervical cancer	0.000491	0.0013	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—STAT3—cervical cancer	0.000486	0.00129	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.00048	0.00127	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000478	0.00127	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—FGFR3—cervical cancer	0.000478	0.00127	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—WNT2—cervical cancer	0.000468	0.00124	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-DPB1—cervical cancer	0.000467	0.00124	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000461	0.00122	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—STAT3—cervical cancer	0.000456	0.00121	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TP53—cervical cancer	0.000451	0.00119	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—AKAP13—cervical cancer	0.000451	0.00119	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—NOTCH2—cervical cancer	0.00042	0.00111	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—EGFR—cervical cancer	0.000414	0.0011	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CASP8—cervical cancer	0.000409	0.00108	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—WNT5A—cervical cancer	0.000389	0.00103	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—TP53—cervical cancer	0.000371	0.000982	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CA9—cervical cancer	0.00037	0.000981	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000365	0.000968	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-DQB1—cervical cancer	0.000365	0.000965	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—WNT5A—cervical cancer	0.000355	0.00094	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CA9—cervical cancer	0.000349	0.000923	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD8A—cervical cancer	0.00034	0.000901	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—CTNNB1—cervical cancer	0.000338	0.000894	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—MTOR—cervical cancer	0.000336	0.000891	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CD4—cervical cancer	0.000336	0.000889	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000307	0.000812	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CTNNB1—cervical cancer	0.000298	0.000789	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—STAT3—cervical cancer	0.000294	0.000779	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—FGFR3—cervical cancer	0.000278	0.000737	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NOTCH2—cervical cancer	0.000273	0.000723	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CA9—cervical cancer	0.000269	0.000712	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—EGFR—cervical cancer	0.000267	0.000708	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—NOTCH1—cervical cancer	0.00026	0.000688	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CA9—cervical cancer	0.000247	0.000655	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CA9—cervical cancer	0.000245	0.000649	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CASP8—cervical cancer	0.000238	0.00063	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—EGFR—cervical cancer	0.000236	0.000625	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HES1—cervical cancer	0.000224	0.000593	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—TP53—cervical cancer	0.00022	0.000583	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CA9—cervical cancer	0.00021	0.000555	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—HES1—cervical cancer	0.000204	0.000541	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TERT—cervical cancer	0.000196	0.000519	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—MTOR—cervical cancer	0.000196	0.000519	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD4—cervical cancer	0.000195	0.000518	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—FGFR3—cervical cancer	0.00018	0.000477	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MTHFR—cervical cancer	0.000179	0.000475	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TERT—cervical cancer	0.000179	0.000474	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CTNNB1—cervical cancer	0.000174	0.00046	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NOTCH1—cervical cancer	0.000169	0.000448	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—FGFR3—cervical cancer	0.000164	0.000435	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CA9—cervical cancer	0.000162	0.000428	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NOTCH1—cervical cancer	0.000154	0.000408	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—STAT3—cervical cancer	0.000151	0.000401	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—MTHFR—cervical cancer	0.00015	0.000398	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—MTHFR—cervical cancer	0.000141	0.000375	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—EGFR—cervical cancer	0.000138	0.000364	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MTOR—cervical cancer	0.000127	0.000335	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CASP3—cervical cancer	0.000116	0.000308	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MTOR—cervical cancer	0.000116	0.000306	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CD4—cervical cancer	0.000115	0.000305	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CTNNB1—cervical cancer	0.000112	0.000297	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—MTHFR—cervical cancer	0.000109	0.000289	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CTNNB1—cervical cancer	0.000102	0.000271	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—MTHFR—cervical cancer	0.0001	0.000266	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—MTHFR—cervical cancer	9.95e-05	0.000264	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—STAT3—cervical cancer	9.79e-05	0.000259	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—STAT3—cervical cancer	8.93e-05	0.000236	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—EGFR—cervical cancer	8.89e-05	0.000236	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—MTHFR—cervical cancer	8.5e-05	0.000225	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—EGFR—cervical cancer	8.11e-05	0.000215	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TP53—cervical cancer	7.47e-05	0.000198	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—MTHFR—cervical cancer	6.56e-05	0.000174	CbGpPWpGaD
